Home Company Team Portfolio News SPECIALIZATION Sanderling focuses on substantial new biomedical market opportunities including emerging technology in the following areas: Small molecule therapeutics Biologics and vaccines Drug delivery Platform technologies Medical devices Diagnostics Digital/eHealth Sanderling utilizes its substantial capital resource base to invest in several new ventures per year, concentrating on opportunities with the most potential for future commercial applications. Historically, Sanderling has demonstrated its strength in identifying promising new technologies and patents long before they are ready to market. The addition of Sanderling funding and business expertise has proved invaluable in developing successful strategies for new venture growth and development. In making its selections, Sanderling looks for innovative technology that has the potential for multiple product applications, as well as entrepreneurs who have outstanding technical backgrounds. Sanderling expects to work in partnership with these entrepreneurs in developing their technology throughout the business-building process. Sanderling’s significant contributions to building new biomedical companies include: Active Seed and Early-stage funding Active management participation during the start-up phase and beyond, as appropriate Developing a value-added business strategy with long-term investment horizons Creating an investment syndicate for further rounds of financing As in any long-term investment vehicle, identifying ventures with strong potential and nurturing them today sows the seeds for tomorrow’s harvest. Following its own best instincts, talents, and strategy, Sanderling continues to bring significant new technologies to market, and achieve successful outcomes for both its portfolio companies and investors. INDUSTRY SPONSORSHIPS AND AFFILIATIONS SAN MATEO OFFICE 1300 S. El Camino Real Suite 203 San Mateo, CA 94402 650-401-2000 F: 650-375-7077 info@sanderling.com MONTREAL, QUEBEC OFFICE 1010 Sherbrooke St. W. Suite 408 Montreal, Quebec H3A 2R7 514-564-6474 info@sanderling.com OUR COMPANY Home About Us Therillia News ©2021 Sanderling Ventures. All Rights Reserved.